The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | Molecular classification, biology-based clinical trials and liquid biopsy in lymphoma
Jessica Okosun, MA, MB, BChir, PhD, MRCP, FRCPath, Barts Cancer Institute, London, UK, highlights the advances around the classification of diffuse large B-cell lymphoma. Dr Okuson discusses how to translate molecular information and data into clinical practice, as well as the utilization of liquid biopsy in lymphoma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
